The Northwell Cancer Institute opened a $1 million high-dose rate brachytherapy radiation medicine suite at the R.J. Zuckerberg Cancer Center, located near the border of Long Island and Queens.
A phase III clinical trial will soon begin testing the evidence collected thus far that points to a stunning prospect: the COVID-19 vaccine—a widely accessible mRNA vaccine already on the market—could make checkpoint inhibitors work better for lung cancer and melanoma patients.
